High proportion of anergic B cells in the bone marrow defined phenotypically by CD21(-/low)/CD38- expression predicts poor survival in diffuse large B cell lymphoma.
Sewa RijalJohanna KokCaitlin CoombesLillian SmythJayde HouriganSanjiv JainDipti TalaulikarPublished in: BMC cancer (2020)
High proportion of anergic B cells in the BM characterized by CD21(-/low)/CD38- expression predicts poor survival outcomes in DLBCL.